Font size

What is the CureMILS Project?

The project - full name 'CureMILS - A reprogramming-based strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh syndrome' - is an exciting research project which aims to develop therapies for mitochondrial DNA-associated Leigh syndrome (MILS).

Professor Prigione explains what the project involves in this 3 minute video.  

IMP is a partner in the project, which is part of the European Joint Programme on Rare Diseases.

Click to watch.

Read more about the project.

© 2021 Int. Mito Patients